UnitedHealth Group raised its 2026 outlook after third-quarter adjusted earnings of $4.69 a share, but one nonrecurring item makes the improvement in medical costs less clean than the headline suggests.
The insurer now expects at least $20.50 in full-year adjusted earnings per share, up from the $19.50 to $20.00 range issued after the second quarter. Third-quarter revenue was $112.7 billion, operating earnings were $6.6 billion and operating cash flow reached $5.1 billion.
The medical care ratio, the share of premium revenue used for medical claims, improved to 88.4% from 89.9% a year earlier. That is encouraging because medical-cost pressure drove much of the industry's recent earnings strain. Yet the quarter included $610 million of favorable prior-period reserve development, meaning estimates for earlier claims proved higher than needed. The release supports current profit but may not recur.
Optum Health offered a second source of improvement. Operating earnings rose to $735 million from $41 million after UnitedHealth exited value-based care markets where it lacked scale. The tradeoff was a 10% decline in Optum Health revenue. Optum Insight and Optum Rx also increased earnings, showing that the recovery was not confined to the insurance unit.
Growth remains uneven. Total medical membership fell to 48.3 million from 50.1 million a year earlier, while Medicare Advantage enrollment has declined by 935,000 since the end of 2025. Consolidated revenue slipped 0.4% even as it exceeded expectations. Better margins on a smaller membership base can lift profit, but it does not resolve the question of sustainable top-line growth.
UnitedHealth's raised guidance is a real positive signal, and the company has returned $5 billion through share repurchases through September 30. Still, the quality of the beat matters. Investors should separate structural gains from exits, pricing and operations from the reserve release, then watch whether the medical care ratio holds as enrollment stabilizes.